This Rare Gene Mutation May Be Linked to Diabetes in Babies Under Six Months: Study Suggests

Written By :  Dr. Bhumika Maikhuri
Published On 2025-10-11 02:30 GMT   |   Update On 2025-10-11 02:30 GMT
Advertisement

A recent study published in the Journal of Clinical Investigation has identified a new genetic cause of neonatal diabetes in infants. The study reveals that mutations in the TMEM167A gene disrupt insulin production in babies diagnosed with diabetes before six months of age.

While it is known that over 85% of neonatal diabetes cases result from genetic mutations, the researchers discovered a previously unidentified link in six babies who also suffered from neurological conditions such as epilepsy and microcephaly. All six were found to have alterations in the TMEM167A gene, prompting further investigation into its role.

Advertisement

To explore the gene’s function, Professor Miriam Cnop’s team at ULB used stem cells that were differentiated into pancreatic beta cells, those responsible for producing insulin. Using CRISPR gene-editing technology, they demonstrated that when TMEM167A is altered, the beta cells activate stress pathways and eventually die, rendering them unable to produce insulin.

Professor Cnop added, “The ability to generate insulin-producing cells from stem cells has enabled us to study what is dysfunctional in the beta cells of patients with rare forms as well as other types of diabetes. This is an extraordinary model for studying disease mechanisms and testing treatments.”

The research confirms that TMEM167A is critical not only for pancreatic function but also for neurons. The discovery opens new avenues for understanding insulin production and could offer valuable insights into broader diabetes research, a condition affecting nearly 589 million people globally.

Reference: Enrico Virgilio et al, Recessive TMEM167A variants cause neonatal diabetes, microcephaly and epilepsy syndrome, Journal of Clinical Investigation (2025). DOI: 10.1172/jci195756

Full View
Tags:    
Article Source : Journal of Clinical Investigation

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News